🔗 Permalink

Inventor profile of:

Harpreet SINGH

City:

München Schwabing

Country:

Germany

Published Applications:

Last publication date:

2020-01-02

Top Assignees for applications by Harpreet SINGH

The entities that hold a legal rights for patent applications filed by inventor SINGH Harpreet:

IMMATICS BIOTECHNOLOGIES GMBH 25 Tuebingen, Germany
INMATICS BIOTECHNOLOGIES GMBH 1 Tuebingen, Germany
IMMAICS BIOTECHNOLOGIES GMBH 1 Tuebingen, Germany
IMMATICS BIOTECHNOLOGY GMBH 1 Tuebingen, Germany

Recent patent applications by SINGH Harpreet

Harpreet SINGH from München Schwabing, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-01-02

US20200000895A1

Human necessities

A*03 restricted peptides for use in immunotherapy against cancers and related methods

#2 | 2019-04-04

US20190100566A1

Chemistry; metallurgy

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#3 | 2019-03-28

US20190092824A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#4 | 2019-03-28

US20190092823A1

Chemistry; metallurgy

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#5 | 2019-02-21

US20190054160A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#6 | 2019-01-31

US20190030075A1

Human necessities

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

#7 | 2019-01-24

US20190023763A1

Chemistry; metallurgy

Uterine cancer treatments

#8 | 2019-01-24

US20190023762A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#9 | 2019-01-17

US20190016779A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#10 | 2019-01-17

US20190015492A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against various cancers

#11 | 2019-01-10

US20190010209A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#12 | 2019-01-10

US20190010208A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#13 | 2019-01-10

US20190010198A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#14 | 2019-01-10

US20190010190A1

Chemistry; metallurgy

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

#15 | 2019-01-03

US20190002526A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#16 | 2019-01-03

US20190002525A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers

#17 | 2019-01-03

US20190002524A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#18 | 2019-01-03

US20190002504A1

Chemistry; metallurgy

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#19 | 2018-12-20

US20180360937A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against various cancers

#20 | 2018-12-20

US20180360936A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against various cancers

#21 | 2018-12-13

US20180353586A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#22 | 2018-12-13

US20180353585A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#23 | 2018-12-13

US20180353584A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#24 | 2018-12-13

US20180353583A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#25 | 2018-12-06

US20180346548A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#26 | 2018-12-06

US20180346538A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#27 | 2018-12-06

US20180344827A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#28 | 2018-12-06

US20180344826A1

Human necessities

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

#29 | 2018-12-06

US20180344825A1

Human necessities

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#30 | 2018-11-29

US20180340019A1

Chemistry; metallurgy

Peptides and combination of peptides for use in immunotherapy against various tumors

#31 | 2018-11-15

US20180327475A1

Chemistry; metallurgy

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#32 | 2018-11-15

US20180327474A1

Chemistry; metallurgy

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

InventorID:

2348640 ⎘